Article Text

PDF
A2.03 The PD-1/PD-L1 axis is modulated by pro-inflammatory cytokines
  1. D Bommarito,
  2. C Hall,
  3. LS Taams,
  4. VM Corrigall
  1. Centre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, UK

Abstract

Background The Programmed Cell Death 1 (PD-1) receptor plays a major role in maintaining self-tolerance. Engagement of PD-1 with its ligand PD-L1 on CD4+ T cells is reported to downregulate inflammatory responses through inhibition of cell proliferation and cytokine production. In inflammatory arthritis (IA), PD-1 is described as overexpressed on synovial fluid (SF) CD4+ T cells compared to peripheral blood (PB) CD4+ T cells while conflicting evidence exists regarding the expression and functionality of PD-L1 during chronic inflammation. The aim of this study was to determine (i) PD-1 and PD-L1 expression on IA SF CD4+ T cells and (ii) the effects of the pro-inflammatory cytokines TNFα and IL-6 on PD-1 ligation in healthy control (HC) CD4+T cells.

Materials and methods CD4+ T cells were isolated from PB of HC or patients with IA and cultured in anti-CD3 or anti-CD3/PD-L1fc chimaera coated plates. IL-6 (10 ng/ml) +/- anti-IL-6R (tocilizumab; 1 ug/ml), or TNFα (10 ng/ml) or acellular SF (0.5%) +/- anti-TNFα (adalimumab; 1ug/ml) were added to the cultures. Proliferation was assessed at day 5 by 3H-thymidine uptake. Day 5 supernatants were analysed by ELISA for soluble PD-1 (sPD-1).

Results IA SF samples were enriched for PD-1+CD4+ T cells compared to PB (n = 6, p = 0.03) while no significant difference was observed in the percentage of PD-L1+ T cells. CD4+ T cells from HC showed a significant decrease in proliferation upon PD-1 ligation (n = 8; p < 0.05) while CD4+ T cells from IA patients appeared more resistant (n = 8; p > 0.05). In HC CD4+ T cell cultures, addition of TNFα or IL-6 completely abrogated PD-L1fc activity (n = 10; p > 0.05). In these cultures, the TNFα and IL-6 effect was neutralised by adalimumab (n = 9) and tocilizumab (n = 6) (p < 0.05). Addition of a-cellular SF (0.5%) to HC CD4+ cell cultures (n = 3) also reduced the effects of PD-1 crosslinking. ELISA analysis showed that both TNFα or IL-6 induced sPD-1 production (n = 7; p < 0.05) and that adalimumab and tocilizumab successfully blocked this effect.

Conclusion We hypothesise that the pro-inflammatory cytokines TNFα and IL-6 modulate CD4+ T cells reactivity to PD-L1 by inducing the release of a soluble form of PD-1 which might interfere with PD-1/PD-L1 signalling.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.